Does Rallies show 13F holders for ISPC?

Yes. Rallies tracks hedge fund and 13F ownership data for ISPC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ISPC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ISPC. It does not provide personalized investment advice.

ISPC (iSpecimen Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

iSpecimen Inc. Common Stock (ISPC) is a publicly traded Healthcare sector company. As of May 21, 2026, ISPC trades at $3.36 with a market cap of $5.17M and a P/E ratio of -0.39. ISPC moved -7.90% today. Year to date, ISPC is -71.09%; over the trailing twelve months it is -92.77%. Its 52-week range spans $3.20 to $332.00. Rallies surfaces ISPC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ISPC stock?

Hedge funds tracked by Rallies that own ISPC include Citadel Advisors and Renaissance Technologies. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for iSpecimen Inc. Common Stock.

ISPC Key Metrics

Key financial metrics for ISPC
Metric	Value
Price	$3.36
Market Cap	$5.17M
P/E Ratio	-0.39
EPS	$-8.30
Dividend Yield	0.00%
52-Week High	$332.00
52-Week Low	$3.20
Volume	150.16K
Avg Volume	0
Revenue (TTM)	$1.03M
Net Income	$-11.10M
Gross Margin	-24.98%

Top Hedge Funds Holding ISPC

Citadel Advisors holds 25.50K shares of ISPC, changed -34.29% as of Jun 30, 2024.
Renaissance Technologies holds 10.00K shares of ISPC, changed -6.47% as of Mar 31, 2024.

Latest ISPC News

iSpecimen Raises $2.5 Million in Private Placement at $5.12 per Share — May 9, 2026
iSpecimen Announces 1-for-40 Reverse Split Reducing Outstanding Shares to 1.316M — Apr 24, 2026
iSpecimen Cuts Biospecimen Transit Times by Up to 85%, Expands EU Network — Apr 9, 2026
iSpecimen Collects 500 Influenza Swabs, Expands CSF and Tissue Supply — Mar 16, 2026
iSpecimen Unveils LLM-Powered AI Agent Automating Biospecimen Matching — Mar 12, 2026

Recent ISPC Insider Trades

Bielak Benjamin bought 18.00K (~$12.96K) on Sep 14, 2023.
Curley Tracy bought 4.40K (~$5.50K) on May 31, 2023.

ISPC Analyst Consensus

ISPC analyst coverage data. Average price target: $0.00.

Common questions about ISPC

Who owns ISPC stock?: Hedge funds tracked by Rallies that own ISPC include Citadel Advisors and Renaissance Technologies. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for iSpecimen Inc. Common Stock.
Does Rallies show 13F holders for ISPC?: Yes. Rallies tracks hedge fund and 13F ownership data for ISPC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ISPC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ISPC. It does not provide personalized investment advice.